Ultra Nasdaq Biotechnology Prosharesのニュース一覧

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Benzinga06:15

FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development

Seeking Alpha01:52

Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart

Seeking Alpha01/06 23:00

Citi's Themes: Top Stocks in AI, Leisure, Fin-tech, Video Gaming, Etc. Vs. Their SA Quant Ratings

Seeking Alpha01/06 22:59

Vaccine Stocks Gain Amid Uptick in Flu, COVID-19, RSV

Seeking Alpha01/06 22:47

SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?

Seeking Alpha01/06 06:32

Regeneron Expands Eye Care Focus With Oxular Buyout

Seeking Alpha01/04 02:12

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

Benzinga01/04 02:08

Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer

Seeking Alpha01/04 00:21

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years

Benzinga01/03 23:00

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Benzinga01/03 20:39

17 Analysts Assess Biogen: What You Need To Know

Benzinga01/03 02:00

Biogen Analyst Ratings

Benzinga01/03 00:15

经历2024年大丰收后，美国ETF或在今年遇挫

智通財経01/02 20:49

Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million

Benzinga01/02 20:38

Analyst Expectations For Amgen's Future

Benzinga01/02 20:00

Amgen Analyst Ratings

Benzinga01/02 19:48

Reported Wednesday, HUTCHMED And AstraZeneca's ORPATHYS-TAGRISSO Therapy Advances In China With Priority NDA Status For MET-Amplified Lung Cancer

Benzinga01/02 13:53

Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025

Benzinga2024/12/31 23:45

Takeda-backed Ascentage Pharma Files for $100M IPO

Seeking Alpha2024/12/31 05:22